This is a past version of the SEER Cancer Statistics Review that includes statistics from 1975 through 2001. If you would like to view the most recent version of the CSR, please visit the CSR Home Page.

On this page:

Contents of the CSR

The files on this page are provided in PDF format.

Summary Figures and Tables
(Excerpts from Overview)
CSR Sections Pages Grouped By Topic
  1. Overview in a Single PDF (PDF, 377 KB)
  2. All Sites (PDF, 104 KB)
  3. Brain and Other Nervous (PDF, 88 KB)
  4. Breast (PDF, 194 KB)
  5. Cervix Uteri (PDF, 76 KB)
  6. Colon and Rectum (PDF, 134 KB)
  7. Corpus Uteri (PDF, 74 KB)
  8. Esophagus (PDF, 88 KB)
  9. Hodgkin Lymphoma (PDF, 84 KB)
  10. Kaposi's Sarcoma (PDF, 39 KB)
  11. Kidney and Renal Pelvis (PDF, 89 KB)
  12. Larynx (PDF, 86 KB)
  13. Leukemia (PDF, 152 KB)
  14. Liver and Bile Duct (PDF, 88 KB)
  15. Lung and Bronchus (PDF, 157 KB)
  16. Melanoma of the Skin (PDF, 91 KB)
  17. Myeloma (PDF, 85 KB)
  18. Non-Hodgkin Lymphoma (PDF, 117 KB)
  19. Oral Cavity and Pharynx (PDF, 87 KB)
  20. Ovary (PDF, 76 KB)
  21. Pancreas (PDF, 88 KB)
  22. Prostate (PDF, 92 KB)
  23. Stomach (PDF, 89 KB)
  24. Testis (PDF, 72 KB)
  25. Thyroid (PDF, 85 KB)
  26. Urinary Bladder (PDF, 98 KB)
  27. Childhood Cancer (PDF, 87 KB)
  28. Childhood Cancer by the ICCC (PDF, 69 KB)   

Revision History

Date Revision Affected Pages

Table I-3 was temporarily removed - The Percent Change and APC for 1950-2001 were incorrectly calculated:

  • For incidence data, the yearly rates for 1950-1972 were age-adjusted using the 1970 standard million population, and the remaining years (1973-2001) were age-adjusted using the 2000 standard million population.
  • The mortality trends were based on rates age-adjusted using the 2000 standard million population.
Temporary removal of:
Table I-3: Summary of Changes in Cancer Incidence and Mortality, 1950-2001 and 5-Year Relative Survival Rates, 1950-2000
04/29/2004 The > 26 years and complete breast cancer prevalence statistics for blacks, both sexes combined were removed. Statistics for both sexes combined is calculated using the male and female complete prevalence statistics. Complete prevalence is not available for black male breast cancer. Table IV-17 (PDF, 10 KB)
04/27/2004 A correction was made to the text in the footnote describing the calculation of SEER incidence and US mortality rates for Hispanics. The table data were not changed, the list of states excluded for Hispanic mortality was incomplete and was corrected. Incidence & Mortality by Race/Ethnicity tables (PDF, 150 KB)
Tables: II-9, III-9, IV-12, IV-13, V-7, VI-14, VI-15, VII-7, VIII-9, IX-9, XI-9, XII-9, XIII-15, XIV-9, XV-14, XVI-9, XVII-9, XVIII-13, XIX-9, XX-7, XXI-9, XXII-7, XXIII-9, XXIV-7, XXV-9, XXVI-9
04/27/2004 Table A-3 was modified to include the SEER Site Recode ICD-O-3 definition rather than the ICD-O-2 definition. Table A-3 (PDF, 23 KB)

Suggested Citation

All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.

Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Mariotto A, Feuer EJ, Edwards BK (eds). SEER Cancer Statistics Review, 1975-2001, National Cancer Institute. Bethesda, MD,, 2004.

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.